Despite limited evidence to prove its drug works, the maker of Vivitrol has used political connections and marketing to push for its use for detoxing.
NYS Entity Status
NYS Filing Date
DECEMBER 31, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2013 - DRUG CRISIS IN OUR BACKYARD, INC.
AROUND THE WEB
- Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product
By ABBY GOODNOUGH and KATE ZERNIKE - Sunday Jun 11, 2017
- Insurers Battle Families Over Costly Drug for Fatal Disease
By KATIE THOMAS - Thursday Jun 22, 2017
The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
- When Opioid Addicts Find an Ally in Blue
By AL BAKER - Monday Jun 12, 2017
Across the country, police leaders are assigning themselves a big role in reversing a complex crisis, and not through mass arrests.
- This Weekend with Gordon Deal June 17, 2017
By email@example.com (Compass Media Networks) - Saturday Jun 17, 2017
The drug crisis is devastating all groups of Americans, how to protect yourself from skin cancer, and what's dad worth this year.
- This Morning with Gordon Deal November 17, 2016
By firstname.lastname@example.org (Compass Media Networks) - Thursday Nov 17, 2016
Donald Trump's transition team reach out to Democrats, Surgeon General calls drug crisis 'a moral test for America' and and the snooze-fest called Thursday Night Football.
- Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
By STEPHANIE CLIFFORD - Thursday Jun 22, 2017
The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]